A novel bisphosphonate minodronate (YM529) specifically inhibits osteolytic bone metastasis produced by human small-cell lung cancer cells in NK-cell depleted SCID mice.

Source:http://linkedlifedata.com/resource/pubmed/id/12705636

Download in:

View as

General Info

PMID
12705636